GLP Watchdog

HeliMeds vs Layla

Neither HeliMeds nor Layla has an FDA warning letter on record. No price lines up like for like. They share brand-name semaglutide pen, but HeliMeds' $1,599 is a prepaid rate.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

HeliMeds / Layla

HeliMeds logo

HeliMeds

7.5/10

Layla logo

Layla

6.8/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$225/moCompounded semaglutide injection
$237/moCompounded oral semaglutide
States
48 states
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit HeliMedsFull review
Visit LaylaFull review

Neither HeliMeds nor Layla pays us. Links to them earn nothing. Scores: HeliMeds 7.5, Layla 6.8. How we are paid

What the record shows

  1. 01

    Neither HeliMeds nor Layla has an FDA warning letter on record.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    No price lines up like for like. They share brand-name semaglutide pen, but HeliMeds' $1,599 is a prepaid rate.

  4. 04

    Only HeliMeds lists a price for compounded semaglutide injection and compounded tirzepatide injection. Only Layla lists a price for compounded oral semaglutide.

  5. 05

    HeliMeds lists 48 states. Layla publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

HeliMeds

Layla

Brand-name semaglutide pen

$1,599/mo

prepaid plan; not compared

$1,399/mo

$16,788 a year

Brand-name tirzepatide pen

$1,396/mo

prepaid plan; not compared

$1,399/mo

$16,788 a year

Compounded semaglutide injection

$225/mo

$2,700 a year

Not sold or not priced
Compounded tirzepatide injection

$285/mo

$3,420 a year

Not sold or not priced
Compounded oral semaglutide
Not sold or not priced

$237/mo

$2,844 a year

Price includes
Medication, clinician visits, shipping
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None; each order is a one-time payment with no auto-billing
None; 30 days' notice
Refunds
All sales final; consult fees not refundable
If a sent prescription order can be canceled, a $100 visit and clinical fee is kept
Early-exit fee
None stated
None stated

Read off each seller’s own pages. HeliMeds: October 17, 2026. Layla: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for HeliMeds

7.5/10
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which Layla does not price
  • Names no compounding pharmacy
Visit HeliMeds

The case for Layla

6.8/10
  • Sells compounded oral semaglutide, which HeliMeds does not price
  • Names no compounding pharmacy
  • Publishes no state list
Visit Layla

Scores

HeliMeds 7.5 · Layla 6.8 out of 10. Six weighted parts.

Value25%

4.1A
vs
B
3.7

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
6.5

Accessibility10%

9.7A
vs
B
5.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

HeliMeds vs Layla: questions

Neither HeliMeds nor Layla has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
No price lines up like for like. They share brand-name semaglutide pen, but HeliMeds' $1,599 is a prepaid rate. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
HeliMeds states you can cancel at any time; refunds: all sales final; consult fees not refundable. Layla states you can cancel at any time; refunds: if a sent prescription order can be canceled, a $100 visit and clinical fee is kept.
Neither HeliMeds nor Layla pays us. Links to them earn nothing. Scores: HeliMeds 7.5, Layla 6.8.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks